Cargando…

Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats

BACKGROUND: This study aimed to explore the potential mechanism of Qishen Yiqi dropping pills (QYDPs) in the treatment of chronic heart failure (CHF) by regulating the expression of lncRNAs during CHF. METHODS: Differences in the expression of the long non-coding RNA (lncRNA), X-inactive specific tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Ying, Chen, Jiaxian, Chen, Yuewu, Su, Yangshen, Wu, Xiaoyan, Zheng, Wanling, Liu, Xianxia, Chen, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264057/
https://www.ncbi.nlm.nih.gov/pubmed/35813728
http://dx.doi.org/10.21037/jtd-22-606
_version_ 1784742889320873984
author Luo, Ying
Chen, Jiaxian
Chen, Yuewu
Su, Yangshen
Wu, Xiaoyan
Zheng, Wanling
Liu, Xianxia
Chen, Lei
author_facet Luo, Ying
Chen, Jiaxian
Chen, Yuewu
Su, Yangshen
Wu, Xiaoyan
Zheng, Wanling
Liu, Xianxia
Chen, Lei
author_sort Luo, Ying
collection PubMed
description BACKGROUND: This study aimed to explore the potential mechanism of Qishen Yiqi dropping pills (QYDPs) in the treatment of chronic heart failure (CHF) by regulating the expression of lncRNAs during CHF. METHODS: Differences in the expression of the long non-coding RNA (lncRNA), X-inactive specific transcript (XIST), in an isoproterenol (ISO)-induced cardiomyocyte hypertrophy model treated with QYDPs was analyzed by reverse transcription quantitative polymerase chain reaction (RT-qPCR). A cell counting kit-8 (CCK8) assay, flow cytometry (FCM), and enzyme linked immunosorbent assay (ELISA) were used to analyze the protective effects of QYDPs on the proliferation rate, apoptosis, myocardial enzyme, oxidative stress, and inflammation of cardiomyocytes, as well as the molecular mechanism of XIST. RESULTS: Our results showed that in the ISO-induced cardiomyocyte hypertrophy model, XIST expression and apoptosis were increased, the cell proliferation rate was decreased, and myocardial enzyme levels increased [i.e., increased lactate dehydrogenase (LDH) and creatine kinase (CK) levels]. Furthermore, cellular oxidative stress [i.e., increased malondialdehyde (MDA) levels and decreased superoxide dismutase (SOD) levels] and inflammatory response [i.e., increased interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α protein secretion] were also promoted. QYDP treatment effectively mitigated the effects of ISO induction. Subsequently, we found that suppressing XIST expression reversed the effect of ISO induction, whereas overexpression (ov) of XIST enhanced the effect of ISO induction. Finally, this study confirmed that QYDP treatment improved the ISO-induced decrease in proliferation, apoptosis, and promotion of oxidative stress and inflammatory response in cardiomyocytes, whereas ov of XIST partially negated the effect of QYDPs. CONCLUSIONS: QYDPs protected H9c2 cells from ISO-induced damage by downregulating XIST expression.
format Online
Article
Text
id pubmed-9264057
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-92640572022-07-09 Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats Luo, Ying Chen, Jiaxian Chen, Yuewu Su, Yangshen Wu, Xiaoyan Zheng, Wanling Liu, Xianxia Chen, Lei J Thorac Dis Original Article BACKGROUND: This study aimed to explore the potential mechanism of Qishen Yiqi dropping pills (QYDPs) in the treatment of chronic heart failure (CHF) by regulating the expression of lncRNAs during CHF. METHODS: Differences in the expression of the long non-coding RNA (lncRNA), X-inactive specific transcript (XIST), in an isoproterenol (ISO)-induced cardiomyocyte hypertrophy model treated with QYDPs was analyzed by reverse transcription quantitative polymerase chain reaction (RT-qPCR). A cell counting kit-8 (CCK8) assay, flow cytometry (FCM), and enzyme linked immunosorbent assay (ELISA) were used to analyze the protective effects of QYDPs on the proliferation rate, apoptosis, myocardial enzyme, oxidative stress, and inflammation of cardiomyocytes, as well as the molecular mechanism of XIST. RESULTS: Our results showed that in the ISO-induced cardiomyocyte hypertrophy model, XIST expression and apoptosis were increased, the cell proliferation rate was decreased, and myocardial enzyme levels increased [i.e., increased lactate dehydrogenase (LDH) and creatine kinase (CK) levels]. Furthermore, cellular oxidative stress [i.e., increased malondialdehyde (MDA) levels and decreased superoxide dismutase (SOD) levels] and inflammatory response [i.e., increased interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α protein secretion] were also promoted. QYDP treatment effectively mitigated the effects of ISO induction. Subsequently, we found that suppressing XIST expression reversed the effect of ISO induction, whereas overexpression (ov) of XIST enhanced the effect of ISO induction. Finally, this study confirmed that QYDP treatment improved the ISO-induced decrease in proliferation, apoptosis, and promotion of oxidative stress and inflammatory response in cardiomyocytes, whereas ov of XIST partially negated the effect of QYDPs. CONCLUSIONS: QYDPs protected H9c2 cells from ISO-induced damage by downregulating XIST expression. AME Publishing Company 2022-06 /pmc/articles/PMC9264057/ /pubmed/35813728 http://dx.doi.org/10.21037/jtd-22-606 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Luo, Ying
Chen, Jiaxian
Chen, Yuewu
Su, Yangshen
Wu, Xiaoyan
Zheng, Wanling
Liu, Xianxia
Chen, Lei
Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
title Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
title_full Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
title_fullStr Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
title_full_unstemmed Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
title_short Qishen Yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating X-inactive specific transcript (XIST) expression in rats
title_sort qishen yiqi dropping pills improve isoproterenol-induced cardiomyocyte hypertrophy by regulating x-inactive specific transcript (xist) expression in rats
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264057/
https://www.ncbi.nlm.nih.gov/pubmed/35813728
http://dx.doi.org/10.21037/jtd-22-606
work_keys_str_mv AT luoying qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats
AT chenjiaxian qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats
AT chenyuewu qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats
AT suyangshen qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats
AT wuxiaoyan qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats
AT zhengwanling qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats
AT liuxianxia qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats
AT chenlei qishenyiqidroppingpillsimproveisoproterenolinducedcardiomyocytehypertrophybyregulatingxinactivespecifictranscriptxistexpressioninrats